Tuesday Apr 8
Reckitt Benckiser Said to Have Edge for Merck OTC Unit
In the battle between global consumer-health companies for a multi billion dollar foot-care, allergy and sun-tan lotion business, Reckitt Benckiser Group Plc has advantages that rivals will be hard pressed to match.
Bayer AG Initiates Phase 3 Trial Of Xofigo (Radium Ra 223...
Bayer AG Initiates Phase 3 Trial Of Xofigo Injection In Combination With Abiraterone Acetate For Asymptomatic Or Mildly Symptomatic Chemotherapy-Naive Patients With Bone Predominant Metastatic Castration-Resistant Prostate Cancer /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. today announced that the company has begun to enroll patients in a ... (more)
Bayer gets EU approval for lung-disease drug
Bayer AG said Monday its pulmonary hypertension drug, Adempas, has been approved by the European Commission for the treatment of two chronic forms of hypertension, chalking up another approval for one of its five key drugs.
Simulations Plus Releases ADMET Predictor Version 7.0
Simulations Plus, Inc. , a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that it has released version 7.0 of its best-in-class ADMET Predictora molecular property prediction software.
Wall Street Journal
Bayer Forecasts Strong Sales Growth
Bayer AG is optimistic about its health-care business through 2016, primarily due to its upbeat forecasts for recently launched pharmaceutical products, and said segments across the board are likely to improve.